Add to ORKGIn 2016, the World Health Organisation set a goal to eliminate viral hepatitis by 2030. Robust epidemiological information underpins all efforts to achieve elimination and this systematic review provides estimates of HBsAg and anti-HCV prevalence in the European Union/European Economic Area (EU/EEA) among three at-risk populations: people in prison, men who have sex with men (MSM), and people who inject drugs (PWID)
This systematic review aimed at estimating chronic hepatitis B (HBV) and C virus (HCV) prevalence in...
The World Health Organization ‘Global Health Sector Strategy on Viral Hepatitis 2016–2021’ aimed at ...
Background: People living with HIV (PLHIV) and people in prison are population groups with a potenti...
In 2016, the World Health Organisation set a goal to eliminate viral hepatitis by 2030. Robust epide...
Abstract Background In 2016, the World Health Organisation set a goal to eliminate viral hepatitis b...
textabstractBackground: In 2016, the World Health Organisation set a goal to eliminate viral hepatit...
Knowledge of hepatitis B and C prevalence, and numbers infected, are important for planning response...
Hepatitis C virus (HCV) is a leading cause of liver-related morbidity and mortality worldwide. In th...
ECDC releases two new reports on hepatitis B and C entitled ‘Surveillance and prevention of hepatiti...
Worldwide, the hepatitis B virus (HBV) and the hepatitis C virus (HCV) cause, respectively, 600 000 ...
Worldwide, the hepatitis B virus (HBV) and the hepatitis C virus (HCV) cause, respectively, 600 000 ...
ECDC releases two new reports on hepatitis B and C entitled ‘Surveillance and prevention of hepatiti...
Background Hepatitis C virus (HCV) is a leading cause of liver-related morbidity and mortality world...
International audienceIntroduction The first World Health Organization (WHO) global health sector st...
Background Hepatitis C virus (HCV) is a leading cause of liver-related morbidity and mortality world...
This systematic review aimed at estimating chronic hepatitis B (HBV) and C virus (HCV) prevalence in...
The World Health Organization ‘Global Health Sector Strategy on Viral Hepatitis 2016–2021’ aimed at ...
Background: People living with HIV (PLHIV) and people in prison are population groups with a potenti...
In 2016, the World Health Organisation set a goal to eliminate viral hepatitis by 2030. Robust epide...
Abstract Background In 2016, the World Health Organisation set a goal to eliminate viral hepatitis b...
textabstractBackground: In 2016, the World Health Organisation set a goal to eliminate viral hepatit...
Knowledge of hepatitis B and C prevalence, and numbers infected, are important for planning response...
Hepatitis C virus (HCV) is a leading cause of liver-related morbidity and mortality worldwide. In th...
ECDC releases two new reports on hepatitis B and C entitled ‘Surveillance and prevention of hepatiti...
Worldwide, the hepatitis B virus (HBV) and the hepatitis C virus (HCV) cause, respectively, 600 000 ...
Worldwide, the hepatitis B virus (HBV) and the hepatitis C virus (HCV) cause, respectively, 600 000 ...
ECDC releases two new reports on hepatitis B and C entitled ‘Surveillance and prevention of hepatiti...
Background Hepatitis C virus (HCV) is a leading cause of liver-related morbidity and mortality world...
International audienceIntroduction The first World Health Organization (WHO) global health sector st...
Background Hepatitis C virus (HCV) is a leading cause of liver-related morbidity and mortality world...
This systematic review aimed at estimating chronic hepatitis B (HBV) and C virus (HCV) prevalence in...
The World Health Organization ‘Global Health Sector Strategy on Viral Hepatitis 2016–2021’ aimed at ...
Background: People living with HIV (PLHIV) and people in prison are population groups with a potenti...